The Biostatistics Core Facility brings together expertise and intellectual resources in biostatistics, clinical trials, epidemiology, statistical computing, and database and information management. The Core Facility has wide involvement in support of Cancer Center research in clinical trials, prevention and cancer control research, genetic and population studies, and translational research. Activities include: 1) protocol development; 2) protocol review; 3) study monitoring; 4) data analysis and reporting; 5) database development and management; 6) applications with large population databases; 7) data services and computer programming; 8) research-related website development; 9) education; and 10) statistical consultation and collaboration. The Core Facility closely supports activities of the Clinical Trials Unit. Biostatisticians are actively involved in review of all protocols as part of the Clinical Trials Development and Review Committee. Recent recruitment of the Core Facility has enhanced the biostatistical support of Cancer Center activities, allowing the fostering of the philosophy that productive research requires high quality biostatistical collaboration. Activities of the Core Facility in support of cancer research are illustrated by work on clinical trial protocol development in developmental therapeutics, data mining (genetic microarray data), genetic epidemiology (such as the Colon Polyp and Colon Cancer Sib Pair Study), behavioral research, development of an interactive Clinical Trials Database, and exploration of large population databases for research on cancer preventive and treatment service delivery. The Core Facility has supported research in each of the Programs in the Cancer Center. Collaboration of Core Facility personnel with Cancer Center investigators on the design, operation, analysis, and interpretation of cancer studies has enhanced the quality of the science.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-14
Application #
6658306
Study Section
Project Start
2002-09-13
Project End
2003-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
14
Fiscal Year
2002
Total Cost
$78,870
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Benson, Bryan L; Li, Lucy; Myers, Jay T et al. (2018) Biomimetic post-capillary venule expansions for leukocyte adhesion studies. Sci Rep 8:9328
Bosca, Federica; Bielecki, Peter A; Exner, Agata A et al. (2018) Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications. Bioconjug Chem 29:234-240
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Morrow, James J; Bayles, Ian; Funnell, Alister P W et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med 24:176-185
Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182
Burger, Denis R; Parker, Yvonne; Guinta, Kathryn et al. (2018) PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice. Biol Blood Marrow Transplant 24:260-266
Shi, Xiaojun; Wang, Bingcheng (2018) Caught in the ""Akt"": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF. Sci Signal 11:
Tartakoff, Alan Michael; Dulce, David; Landis, Elizabeth (2018) Delayed Encounter of Parental Genomes Can Lead to Aneuploidy in Saccharomyces cerevisiae. Genetics 208:139-151
Gromovsky, Anthony D; Schugar, Rebecca C; Brown, Amanda L et al. (2018) ?-5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators. Arterioscler Thromb Vasc Biol 38:218-231
Ignatz-Hoover, James J; Wang, Victoria; Mackowski, Nathan M et al. (2018) Aberrant GSK3? nuclear localization promotes AML growth and drug resistance. Blood Adv 2:2890-2903

Showing the most recent 10 out of 1227 publications